Education
About Us
Working with TipRanks
Follow Us
Innovative Medtech (IMTH)
OTHER OTC:IMTH
Total Valuation
Innovative Medtech has a market cap or net worth of $31.51M. The enterprise value is ―.
Market Cap$31.51M
Enterprise Value―
Share Statistics
Innovative Medtech has 52,518,963 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding52,518,963
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Innovative Medtech’s return on equity (ROE) is 1.45 and return on invested capital (ROIC) is 238.90%.
Return on Equity (ROE)1.45
Return on Assets (ROA)-12.18
Return on Invested Capital (ROIC)238.90%
Return on Capital Employed (ROCE)1.24
Revenue Per Employee60.83K
Profits Per Employee-264.63K
Employee Count30
Asset Turnover2.80
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Innovative Medtech is -1.35. Innovative Medtech’s PEG ratio is 0.16.
PE Ratio-1.35
PS Ratio0.00
PB Ratio-2.61
Price to Fair Value-1.96
Price to FCF-485.22
Price to Operating Cash Flow-142.41
PEG Ratio0.16
Income Statement
In the last 12 months, Innovative Medtech had revenue of 1.82M and earned -7.94M in profits. Earnings per share was -0.33.
Revenue1.82M
Gross Profit1.82M
Operating Income-4.27M
Pretax Income-7.94M
Net Income-7.94M
EBITDA-7.67M
Earnings Per Share (EPS)-0.33
Cash Flow
In the last 12 months, operating cash flow was -88.94K and capital expenditures 44.56K, giving a free cash flow of -44.38K billion.
Operating Cash Flow-88.94K
Free Cash Flow-44.38K
Free Cash Flow per Share>-0.01
Dividends & Yields
Innovative Medtech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.08
52-Week Price Change-14.29%
50-Day Moving Average0.48
200-Day Moving Average0.41
Relative Strength Index (RSI)70.17
Average Volume (3m)123.00
Important Dates
Innovative Medtech upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Innovative Medtech as a current ratio of 0.07, with Debt / Equity ratio of -27.45%
Current Ratio0.07
Quick Ratio0.07
Debt to Market Cap0.17
Net Debt to EBITDA-0.27
Interest Coverage Ratio-21.47
Taxes
In the past 12 months, Innovative Medtech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Innovative Medtech EV to EBITDA ratio is -1.67, with an EV/FCF ratio of -54.83.
EV to Sales7.02
EV to EBITDA-1.67
EV to Free Cash Flow-54.83
EV to Operating Cash Flow-70.00
Balance Sheet
Innovative Medtech has $98.00 in cash and marketable securities with $1.33M in debt, giving a net cash position of $1.33M billion.
Cash & Marketable Securities$98.00
Total Debt$1.33M
Net Cash$1.33M
Net Cash Per Share$0.03
Tangible Book Value Per Share-$0.23
Margins
Gross margin is 79.93%, with operating margin of -234.21%, and net profit margin of -435.03%.
Gross Margin79.93%
Operating Margin-234.21%
Pretax Margin-435.03%
Net Profit Margin-435.03%
EBITDA Margin-420.50%
EBIT Margin-424.12%
Analyst Forecast
The average price target for Innovative Medtech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―